• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

Testing set for ArteFill’s use in treating acne scars

St. Petersburg, Fla. - Testing is set to begin on ArteFill (polymethylmethacrylate, Artes Medical) for the treatment of acne scars and other depressed atrophic scars, reports MedicalNewsToday.com. St. Petersburg-based dermatologist James Spencer, M.D., will head the study.

St. Petersburg, Fla. - Testing is set to begin on ArteFill (polymethylmethacrylate, Artes Medical) for the treatment of acne scars and other depressed atrophic scars, reports MedicalNewsToday.com. St. Petersburg-based dermatologist James Spencer, M.D., will head the study.

ArteFill already is approved to treat nasolabial folds. Dr. Spencer, who also serves as professor of clinical dermatology at Mt. Sinai School of Medicine, says he expects to enroll 15 patients by the end of March for testing of the filler’s use in treating acne and other atrophic scars.

Dr. Spencer says that 30 days after their ArteFill treatment, patients will be assessed and photographs clinically graded to determine degree of scar correction. Patients will be followed for a year post-treatment. After the study is completed, its findings will be submitted and are expected to be published in a peer-reviewed dermatology journal.

The study will be funded under a research grant from Artes.

Related Videos
Ted Lain, MD, MBA, FAAD, is featured in this series.
Ted Lain, MD, MBA, FAAD, is featured in this series.
Ted Lain, MD, MBA, FAAD, is featured in this series.
E. James Song is featured in this video series.
E. James Song is featured in this video series.
© 2024 MJH Life Sciences

All rights reserved.